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This paper contains the following sections, in approximate chronological order. 
Early years, Scientific research on energy metabolism, Clinical teaching, Evidence 
on health risks, Slow recognition of obesity in diabetes, Depression and war, 
some Obesity research continued in the 1950s and 1960s, New approaches to 
management, a Universal standard weight for height, Luxuskonsumption, Calo-
ries (incompletely) replaced by Joules, Food intakes of obese people, Genetics, 
unexpected Surge of obesity from 1980, Diabetes, Scarcity of effective, safe 
drugs for obesity, Leptin and Ghrelin stimulate basic research, Why has the 
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EARLY YEARS 
Obesity has probably affected some humans 
since hunter gatherers evolved into agricul-
turalists, cities were built and a rich minority 
could eat as much as they wanted. 
Hippocrates, in the 5th century BC [1] 
taught that fat people who want to reduce 
should take their exercise on an empty 
stomach and sit down to their food out of 
breath. Without recovering breath they 
should, before eating drink some diluted 
wine, and then meat should be dished up with 
sesame seeds seasoning. The meat should 
also be fat as the smallest quantity of this is 
filling. They should only take one meal a day, 
go without baths, sleep on hard beds and 
walk about with as little clothing as possible. 
These principles of management might still 
be acceptable today: exercise; only one meal a 
day based on fatty meat for satiety. 
Hippocrates also included among his 
aphorisms that those who are naturally very 
fat are apt to die earlier than those who are 
slender [2]. 
There are no statistics for the prevalence 
of obesity until the 20th century. Only one 
very fat man appears in the Bible, Eglon, king 
of Moab (Judges [3], [17]) (the first direct 
demonstration of abdominal obesity). Only 
one fat main character appears in 
Shakespeare’s plays, Falstaff. 
Three British kings were very fat late in 
their lives: William the Conqueror, Henry VIII 
and George IV. Trowell [3, 4] looked into the 
history of obesity, from literature and art and 
thought that obesity became common in the 
English upper classes in the late 18th century. 
In that period Samuel Johnson, himself 
overweight, had this to say about a man much 
incommoded by corpulency (the precursor of 
our word “obesity”): “He eats too much, sir”, 
to which Boswell replied: “I don’t know, sir” 
You will see one man fat who eats moderately 
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and another lean who eats a great deal”. 
Johnson again: “Nay, sir, whatever may be the 
quantity that a man eats, it is plain that if he is 
too fat, he has eaten more than he should 
have done” [5]. That conversation still con-
tinues. 
The first dietary prescription for treat-
ment of obesity was perhaps in a best-selling 
pamphlet self-published by Mr William Ban-
ting in 1863. He lost 35 pounds on a diet of 
meat or fish three times a day, a little fruit 
and leafy vegetables and several glasses of 
wines. This successful, low carbohydrate, high 
protein diet was prescribed by his ear 
surgeon, Dr William Harvey (not the disco-
verer of circulation of the blood), apparently 
for hearing loss because of fatty deposits 
obstructing his Eustachian tubes [6, 7]. Ban-
ting’s luxurious diet reappeared in modern 
versions as the Atkins diet in 1972 [140, 142]. 
Charles Dickens in Pickwick Papers (1837) 
described a fat boy who kept falling asleep. 
Burwell (in 1956) [8] put this complication of 
obesity in the medical literature and demon-
strated that the episodic somnolence is due to 
hypoventilation and hypercapnia. Osler had 
in the meantime described this “Pickwickian 




SCIENTIFIC RESEARCH ON ENERGY 
METABOLISM 
Scientific understanding of energy metabol-
ism started with Lavoisier, father of modern 
chemistry and the founder of nutritional 
science. Carbon dioxide had been discovered 
by Black in 1757, hydrogen by Cavendish in 
1766, nitrogen by Rutherford in 1772 and 
oxygen by Priestley in 1774. They were not 
given these modern names and their func-
tions were misunderstood. It required the 
brilliant mind of Lavoisier to meld these 
miscellaneous achievements into a harmo-
nious whole around 1780 [10]. A monument 
to him in Paris bears this inscription: 
“Analysis and synthesis of air – Composition 
of oxides and acids – composition of water – 
Theory of combustion – Respiration and 
animal heat – Permanence of weight of matter 
and simple substances – Imponderable nature 
of heat and its role in chemistry”. 
Lavoisier discovered oxidation and named 
the gas (that Priestley had called dephlogisted 
air) oxygen. Lavoisier and Laplace put a 
guinea pig in a very small closed chamber 
surrounded by ice. They measured the 
amount of ice melted over a 10 hour period 
and over the same time the amount of carbon 
dioxide (air fixe’) given out by the animal. 
They also measured the heat produced when 
a known amount of carbon was burnt in their 
calorimeter [11]. 
They realised that the heat produced by 
the animal and the transformation of oxygen 
to carbon dioxide were similar processes. 
Respiration in animals is essentially the same 
as chemical combustion. Lavoisier even 
measured oxygen consumption in a human 
subject and showed it increased after food 
and after exercise. 
Tragically, Lavoisier was guillotined in 
1794 during the Terror that was part of the 
French revolution. He was a minor aristocrat 
and worked as a public servant as well as a 
part-time scientist. His execution has been 
called the most criminal act of the Revolution. 
There was a directly transmitted intellec-
tual inheritance from Lavoiser through his 
associate Berthollet to his pupil Gay-Lussac in 
Paris. Justus Liebig from Germany worked in 
Gay-Lussac’s laboratory and then set up his 
own laboratory in the small German town of 
Giessen, where he was appointed professor of 
chemistry at the university in 1824 (when 21 
years old) [11]. Liebig developed organic 
chemistry and became world famous. His 
contribution to agriculture was fundamental. 
Of relevance here, he asserted that (dietary) 
protein is consumed when muscles exercise. 
In 1852 he moved to be professor of 
chemistry at the University of Munich. 
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Carl von Voit was a student of Liebig’s at 
Munich. Around 1860 he measured the urea 
excretion of dogs at rest and with exercise 
and was astonished to find no difference. 
Then in 1866 Fick and Wislicenus (professors 
of physiology and chemistry in Zurich) 
climbed a 1656m high mountain after going 
on a protein-free diet. They did not feel 
exhausted despite this diet and only excreted 
5.5g nitrogen in the day. Late in his life Liebig 
admitted he had been wrong in asserting that 
protein is used for muscular work. In 1863 
Voit was appointed professor of physiology at 
the University of Munich. He headed the 
leading research group investigating meta-
bolism. 
Voit and colleagues established the prin-
ciples of nitrogen balance and found the 
effects of changing intake level, of different 
dietary proteins, of adding non-protein calo-
ries and of starvation. Amino nitrogen serves 
as a marker in following what happens to 
protein economy in the body. They already 
used faecal period markers. Voit built the first 
human metabolic chamber (1861), with 
money from King Maximillian II of Bavaria. It 
had a small room, to hold a bed or bicycle 
ergometer. Air coming in and out was con-
tinuously analysed for carbon dioxide. He had 
a smaller respiration apparatus for dog ex-
periments. This complicated set of pumps, 
meters and bottles is illustrated in the front of 
Lusk’s classic book [12]. 
Summarizing his work with Pettenkofer, 
Voit recalls “Imagine our sensations as the 
picture of the remarkable processes of the 
metabolism unrolled before our eyes… We 
found that in starvation protein and fat alone 
were burned, that during work more fat was 
burned and that less fat was consumed 
during rest, especially during sleep; that the 
carnivorous dog could maintain himself on an 
exclusive protein diet, and if to such a protein 
diet fat were added, the fat was almost 
entirely deposited in the body; that carbohy-
drates, on the contrary, were burned no 
matter how much was given, and that they, 
like the fat of the food protect the body from 
fat loss…” [12]. 
Max Rubner was the most eminent of 
Voit’s pupils. He worked out the principles of 
energy metabolism that we use today. In 
Munich, he showed that the energy value of 
protein is less when someone eats it than it is 
in a bomb calorimeter because of losses (urea 
and other substances) in urine. He was first to 
produce the energy values 4.1 Cal, 4.1 Cal and 
9.3 Cal per gram for protein, carbohydrate 
and fat respectively (1879). He showed that 
the same calorie intake of any two of these 
give the same heat production in an animal – 
“the isodynamic law”. He moved to be 
professor in Marburg in 1885 and there 
constructed the first reliable animal respira-
tion calorimeter. He found that the energy 
production measured fasting and at rest, the 
Grundumsatz is constant for the individual 
and the fundamental base of energy expendi-
ture. Increased energy output after food is 
due to additional biochemical reactions (Lusk 
in 1912 translated Grundumsatz as “basal 
metabolism”). A dog in the calorimeter for 45 
days used 17,349 Cal calculated from respira-
tion and produced 17,406 Cal as heat. This 
confirmed in an animal the first law of ther-
modynamics, the law of conservation of ener-
gy. In 1891 Rubner was invited to Berlin to 
take Robert Koch’s place as professor of 
hygiene. He did more experiments confirming 
the law of conservation of energy. He collec-
ted data on basal metabolism of various 
animal species and propounded the surface 
area law – that the basal metabolism is pro-
portional to a mammal’s or person’s surface 
area. He also discovered the specific dynamic 
action of foodstuffs, protein being most 
potent [10, 12, 13]. Rubner and Karl Thomas 
worked together to find the minimum 
amount of protein needed by man. Thomas 
went on in classic experiments to estimate 
the “biological values” of major dietary 
proteins in humans. 
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Compared with today Rubner was very 
economical in his use of animals and human 
subjects – all under n=6 [14]. “… a genius who 
drew correct conclusions from data inade-
quate for any other man.” [15]. 
When we calculate the energy value of 
foods or estimate energy requirements from 
height and weight (hence surface area) we 
are using Rubner’s principles of energy meta-
bolism. 
WO Atwater, an American who studied 
under Voit in Munich and was a friend of 
Rubner’s, built a functioning respiration calo-
rimeter for human subjects at Wesleyan Uni-
versity, Connecticut in collaboration with EB 
Rosa, the professor of physics. The calori-
meter was funded by the US government. 
Heat produced in the room was measured 
with circulating water, and CO2 was collected 
over soda lime. It took 12 years to perfect and 
a team of assistants to work it. Garrow takes 2 
pages to describe the equipment and its 
operation [16], Lusk takes four pages [12] 
and provides a table of results of subjects 5 to 
10 in 1899. The differences between heat 
observed and estimated from respiration 
ranged between -4.1% and +1.4%: These and 
later experiments confirmed the law of con-
servation of energy in man. 
“It is possible to make measurements (like 
Atwater’s) on a human subject over a period 
of several days with the precision customary 
in the physical sciences. It is possible but 
needed the skill, vigilance and dedication now 
reserved for exploits such as landing a man 
on the moon” [16]. 
Atwater’s work established the essential 
quantitative knowledge on which all assess-
ments of human energy needs are based. 
Before concentrating on calorimetry, Atwater 
ran an extensive programme on the chemical 
composition of American foods, measuring 
also energy values in a bomb calorimeter and 
including 97 human digestibility experiments. 
The “Atwater factors” 4, 9 and 4 Kcal /gram 
for protein, fat and carbohydrate (by differ-
ence) were published in 1899 [17]. They are 
used when water, protein and fat have been 
analysed, to calculate the calorie value of a 
food. They are almost the same as the factors 
that Rubner had introduced. 
The science and technology of human calo-
rimetry had spread to the USA. Graham Lusk 
was one of Voit’s PhD students in Munich. He 
returned to the USA as professor of phy-
siology at Cornell University Medical School, 
NYC. He did respiration calorimetry with 
dogs, confirming the constancy of basal 
metabolic rate (BMR) under standard 
conditions, and wrote the classic textbook, 
“The Elements of the Science of Nutrition” 
[12]. 
FG Benedict trained with Atwater. He set 
up a human calorimeter at the Carnegie 
Institute in Boston where he studied the 
changes in chemical and energy metabolism 
during undernutrition. In 1912 he made daily 
multiple measurements on a man who fasted 
for 31 days: heat production went down 28% 
after 3 weeks, more than body weight (16%) 
[18]. Later, during World War I, Benedict and 
colleagues had 22 subjects each eat a 
restricted diet for approximately 3 months 
(interrupted over Thanksgiving and Christ-
mas). They lost 7 to 11% of body weight and 
had much larger reductions of basal meta-
bolism per kg; so this fall in metabolism was 
not all due to loss of tissue [19]. 
During World War II another large and 
comprehensive study of underfeeding healthy 
men was made by Ancel Keys and colleagues 
at the University of Minnesota. 32 volunteers, 
conscientious objectors to military service, 
went through 24 weeks of carefully con-
trolled semi-starvation and their average 
weight went from 69 to 53 kg (23%less). 
Again the basal metabolism went down more 
than would be expected from the reduced 
body size. Per man it declined to 63% of start 
value, per m2 to 70% and per kg to 83%. 
Many other measurements were made, all 
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written up in a 2 volume report (1385 pages) 
[20]. 
During the 1920s research interest shifted 
away from energy metabolism and calori-
metry. Biochemists became interested in 
enzyme function, and nutritionists were busy 
searching for new vitamins [21]. 
For Gowland Hopkins “These calorimeter 
studies, invaluable in themselves, were 
leading to doctrinal teaching that contained 
inherent errors… The assumption that car-
bohydrate and fats can replace each other 
indefinitely in a diet, so long as the total 
energy supplied remains the same has led to 
serious errors in practical dietetics… The 
newly discovered vitamins contribute little or 
nothing to the energy factor in nutrition.” 
[22]. 
Measurement of BMR was still used 
clinically (with a portable spirometer to 
measure CO2 production) for diagnosing 
over- or under- activity of the thyroid [23] 
until 1950, when less cumbersome chemical 





Clinical understanding of obesity in the early 
20th century was in a far different world. 
Osler’s major textbook in 1904 [24] had two 
pages on obesity (grouped under “Consti-
tutional Diseases”) of a total 1182 pages. “A 
condition for which we are consulted in three 
groups of cases. First, there are persons of 
both sexes who have a hereditary tendency to 
obesity. Secondly, in this country particularly, 
there is an increasing number of cases of 
obesity in children, associated with bad 
habits in eating, and usually carelessness and 
lack of control on the part of parents. Thirdly, 
and most frequently, we are consulted by 
women at the middle period of life, who are 
troubled with an overgrowth of fat… A great 
many stout persons enjoy unusual vigor. Nor 
is obesity always associated with over-
eating… Too much food and too little exercise 
are largely responsible in about half of the 
cases, but in the hereditary ones these factors 
do not prevail… Gout is an important agent in 
many cases”. This seems to reflect Osler’s 
private practice. On treatment Osler’s advice 
was not very practical. He set out a detailed 
diet with prescribed food or drink at 8, 10, 12, 
1, 3, 4, 6 and 8 o’clock (including 2 glasses of 
wine). These frequent feeds are “to obviate 
the tendency to weakness which these 
patients often experience”. Then “in the 
treatment of extreme obesity it is very much 
better that the patient should be in hospital 
or under the care of a nurse, who will 
undertake the proper weighing and 
administration of the food”. 
A recurring problem with obesity is fat 
people who insist they eat less than average. 
Van Noorden [25] in 1907 classified obesity 
into exogenous due to overeating, or endo-
genous where the cause is internal. Engelbach 
(1932) [26] stated that endogenous obese 
people do not respond to diet and exercise, 
while those with the exogenous variety do. 
Fröhlich in 1901 reported a single patient, 
a boy who became moderately fat in 
adolescence. He had headaches and left-sided 
blindness from optic atrophy. His penis was 
infantile and embedded in fat. Skull X-ray 
showed erosion of the back of the pituitary 
fossa. Operation in Vienna by the nasal route 
removed an adenoma the size of a hazelnut. 
The patient recovered from the operation but 
as an adult (at 26 y) continued to be of 
infantile habitus and still had deposits of fat 
[27]. Subsequent opinion is that the tumour 
was probably in the hypothalamus, not the 
pituitary. 
A 1926 British book on obesity by Leonard 
Williams MD [28] starts: “There are only two 
kinds of obesity- the one is alimentary in 
origin, and is caused by surfeit; the other is 
endocrine in origin and is caused by 
underaction of an endocrine gland”. 
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In the 1913 edition of Osler’s textbook of 
Medicine [9], 20 of the 30 lines on etiology of 
obesity were about endocrine possibilities, 
including Fröhlich’s syndrome. In Price’s text-
book (1930) 28 out of 48 lines on pathology 
were about likely endocrine gland involve-
ment in obesity [29]. By 1952 the new David-
son’s textbook of medicine [30] still had 
Exogenous and Endogenous causes of obesity, 
but “Endocrine factors are often blamed for 
obesity, though seldom on any good evidence. 
Obesity is NOT a characteristic feature of 
either hypothyroidism or anterior pituitary 
deficiency…Appetite is a primitive urge 
regulated by the hypothalamus: Damage to 
this area of the brain occasionally results in 
obesity (eg. In Fröhlich’s syndrome)”. 
An editorial in the BMJ in the Christmas 
1958 issue [31] remarked that “25 years ago 
obesity was generally held to derive from 
endocrine causes, known or unknown, so that 
any obese woman was suspected of Cushing’s 
disease and too many fat boys were referred 




EVIDENCE ON HEALTH RISKS 
“Moderate obesity was considered a sign of 
health…until the 20th century, and some 
societies still consider it healthy. The positive 
attributes of body fat were extolled by early 
fertility symbols (eg. The Venus of Willen-
dorf) from prehistoric times, by the ancient 
Greeks, and by Shakespeare” [32] (“Let me 
have men about me that are fat…”). 
Actuaries with large life insurance com-
panies started to notice from around 1903 
that people above average weight for height 
who applied for life insurance were more 
likely to die young, and hence less profitable 
to insure [33]. 
A large study of men with data from 1909 
to 1928 from 32 life insurance companies 
reported in 1932 that men originally over-
weight had mortality well above average at 
every age, and in general the greater the 
degree of overweight, the higher the 
mortality. The highest death rates were from 
degenerative cardiovascular and renal dis-
eases, diabetes and cirrhosis of the liver [34]. 
Another study by the Union Central Life 
Insurance Company also reported in 1930 on 
men with substandard insurance because of 
overweight. Mortality from cardiovascular 
renal disease was 60% above and from 
diabetes it was 2.5 times above the rates for 
normal-weight men [35]. 
A study of insured women for the Life 
Insurance Medical Directors found that in 
overweight women, excess mortality from 
diabetes and gallbladder disease was three 
times as high as in normal-weight women; 
cardiovascular–renal deaths were also 50% 
higher in women who were obese [34]. 
Tables of ideal or desirable weight for 
height were first published by the Metro-
politan Life Company of New York in 1942-3 
[33]. The Society of Actuaries Build and Blood 
Pressure studies in 1959 and 1979 confirmed 
the earlier mortality risks of obesity and were 
used for new sets of desirable weights, 
complicated by 3 different frame sizes, in 
1959 [36], which were revised in 1983 [37]. 
Epidemiologists regarded these statistics 
with suspicion because not everyone takes 
out life insurance and those that did have 
high socio-economic status and were mostly 
men. In the Seven Country study there was no 
clear relationship of relative weight or skin-
folds with coronary heart disease (CHD). In 
most of the other 13 classic prospective 
studies of risk factors for CHD reporting 1963 
to 1972 overweight (assessed in different 
ways) was not a risk factor or only under 
certain conditions [38]. Ancel Keys was criti-
cal of the life insurance companies biased 
samples and inadequate entry examination 
data [39]. Then, in the later prospective study 
in Gothenburg neither body mass index (BMI) 
nor sum of skinfolds predicted CHD, stroke or 
death in men, but waist/hip circumference 
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did [40]. Abdominal or central obesity is now 
one of the criteria for diagnosis of the “meta-
bolic syndrome” [41]. 
 
 
SLOW RECOGNITION OF OBESITY IN 
DIABETES 
When insulin became available for treatment 
of diabetes around 1923, physicians were 
preoccupied with insulin usage, hypogly-
caemia and strict dietetic control of carbo-
hydrate and sugar intake. The focus was on 
those diabetic patients prone to develop keto-
acidosis. Joslin, however, as early as 1921 
produced impressive evidence that “diabetes 
is largely a penalty of obesity” [42].  In his 
1,000 cases, 10% were underweight (they 
were mostly young), 16% weighed within 5% 
of average normal weight and 74% were 
overweight (+6 to +71% over). But textbooks 
of medicine barely mentioned obesity in their 
chapters on Diabetes. Osler’s textbook gave 
obesity 2 lines in 1929 [43] and 5 lines (out of 
18 pages) in 1942 [44]. Price’s textbook in 
1930 [29] gave a line to obesity (as one of 
four exciting causes, another of which was 
anxiety). 
In 1938 Newburgh drew attention to the 
common type of middle aged diabetic patient 
who, when able to lose weight lost all symp-
toms of diabetes, glucose in the urine and 
hyperglycaemia [45]. Sir Harold Hinsworth in 
1939 hypothesized [46] that in diabetes the 
diminished ability of the tissues to utilise 
glucose could be either due to insufficient 
secretion of insulin OR to insensitivity to 
insulin. When Yalow (2
[47
) and Berson (1960) 
found how to assay plasma insulin with 
radioimmunoassay – that they had invented – 
] the two types of diabetes became much 
clearer. Type 2 is more common, due to 
insulin resistance and closely related to 
obesity. 
 
(2) Nobel prize, 1977 
By 1953 obesity was placed in the middle 
of the Diabetes chapter in Davidson’s new 
textbook of medicine: “The majority of 
patients who first develop diabetes in middle 
life are obese…In obese diabetics the essential 
principle is to impose a restriction of both 
carbohydrate and calories in order to bring 
the weight down to standard levels. This may 
be all that is needed to stop the glycosuria” 
[30]. Confirmation of the close association of 
obesity and diabetes came from Kelly West’s 
epidemiological study in 11 countries [48] 
and the American Cancer Society’s long-term 




ECONOMIC DEPRESSION AND WAR 
Obesity was replaced by under- and 
malnutrition in the concern of nutrition 
researchers in the 1930s when there was eco-
nomic depression and widespread unemploy-
ment and the 1940s, the time of World War II 
with massive destruction in Europe and S.E. 
Asia and starvation over Europe [50]. 
In Britain, with well designed food 
rationing and widespread national nutritional 
advice the population was just adequately fed 
and nourished, and distribution was equa-
lised. There were careful records of food 
moving into consumption; but measurements 
of body weight were rare. They were lower 
than in North America and there was little 
“middle aged spread” [51]. In continental 
Europe there was partial starvation in the 
1940s [52]. This scarcity of calories had two 
health benefits: a dramatic decline in deaths 
from diabetes (in older people) in Britain that 
Himsworth showed to relate to reduced fat 
consumption [53], and less dental caries in 
children. By 1946 exciting nutrition research 
was on malnourished children in Jamaica, 
Guatemala, Kampala, Cape Town etc. In 
Britain after the success of the rationing 
system and with (nearly all) the essential 
nutrients discovered it could have seemed 
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that most of the scientific problems with 
nutrition had been solved.  Oxford University 
refused a grant to establish a department of 
human nutrition because its experts advised 
that all nutritional problems would be solved 
within 10 years and there would be nothing 
left to study [54]! 
 
 
SOME OBESITY RESEARCH CONTINUED IN 
THE 1950s AND 1960s 
Jean Mayer 1953 - 1955 proposed and 
developed the GLUCOSTATIC theory, that a 
fall of blood or tissue glucose stimulates 
appetite [55]. The sensitive tissue might be 
the ventro-medial nucleus (VMH) of the 
hypothalamus, which has an affinity for 
glucose. Injection of (toxic) gold thioglucose 
damages the VMH and leads to hyperphagia 
and obesity in mice. 
Stunckard describes his own disappoint-
ments as a researcher doing human experi-
ments to test the glucostatic theory [56]. The 
control of food intake is more complex. 
Mellinkoff at about the same time pro-
posed appetite signals from PROTEIN or 
amino acids [57]. Dietary protein induces 
satiety in the short term, and a diet of low 
protein foods leads to increased appetite for 
protein-containing foods [58] in subhuman 
species as well as humans [59]. This principle 
is used in some contemporary weight-
reducing diets, such as the CSIRO Total 
Wellbeing Diet [60]. 
Kennedy (in Britain) in 1953 proposed a 
system whereby the amount of BODY FAT 
somehow signals the hypothalamus to control 
energy intake or expenditure and tends to 
maintain body fat and weight [61]. Forty 
years later, a mechanism for this system was 
provided by the discovery of leptin (see 
below). 
A portable gas meter that takes small 
samples of expired air, the Max Planck 
respirometer was developed in Germany 
around 1950. It weighed only 3 kg, is worn as 
a rucksack and could be used to measure 
energy expenditure of active moving people, 
which was not possible with the Douglas bag. 
Durnin and Passmore measured energy 
expenditure of industrial workers, coal 
miners, squash players and many other 
activities. They combined their results with 
literature findings in a 1967 book Energy, 
Work and Leisure [62]. Its information is 
valuable for people wanting to control weight 
with exercise, though the energy expendi-
tures of blue collar workers are now much 
less than they were in the 1960s. 
Stunkard appears to have been first to find 
a clear relationship between SOCIAL CLASS 
AND OBESITY [63] in a population sample of 
1660 adults in Midtown Manhattan, NYC. 
Obesity occurred in 30% women of low socio-
economic status, 16% of those in the middle 
status and only 5% of the upper status [64]. 
There were also differences in obesity by 
ethnic background. Trends in men were less 
marked in the same direction. In a smaller 
sample from two contrasting general prac-
tices in London, Silverstone et al [65] found 
low social class women had twice the 
prevalence of overweight (not obesity – the 
paper’s title is misleading). In older men the 
highest weights were in the middle class, 
probably because of more physical activity at 
work in the lower SE group. In Tecumseh, 
Michigan sum of 4 skinfolds decreased with 
increasing education or income level in 
women but it increased with income level in 
men [66]. These and subsequent reports from 
different parts of the world are important for 
treating and preventing obesity, because they 




NEW APPROACHES TO MANAGEMENT 
In 1959 Stunkard looked into the success of 
obesity clinics. In a large teaching hospital 
only 12% of very obese people were able to 
lose 20lb (or 10kg); 28% never returned after 
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the first visit and 2 years after the end of 
treatment only 2 patients had maintained 
their weight loss [67]. This was surely a 
stimulus to try and improve on the 
management at that time! 
One approach was Therapeutic STARVA-
TION. In the 1960s several groups reported 
this drastic treatment. Drenick et al starved 
11 obese patients in hospital in Los Angeles 
[68] for 12 to 117 days. Thomson et al in 
Glasgow starved 13 patients in hospital for 25 
to 249 days [69]. All they took by mouth was 
water and multivitamin tablets (containing 4 
or 6 vitamins). Hunger was not as distressing 
as in partial starvation. There was some 
ketosis but no ketoacidosis. Plasma uric acid 
increased and blood pressure fell. But it was 
surprising how tolerable were the side effects 
and how large the losses of weight. 
In 1969 a young women (20y) fasted for 
210 days and her weight declined from 118 to 
her ideal weight 60 kg. On the 8th day of 
refeeding she died of ventricular fibrillation 
[70]. Post mortem showed fragmentation of 
cardiac myofibrils. Correspondence opinions 
considered that too much lean body mass had 
been lost, that it was dangerous to lose more 
than 33-40% of the original body weight and 
monitoring of potassium status might have 
been inadequate. Instead of total starvation, 
requirement amounts of protein (about 30g 
protein or 120 Kcal) should be provided to 
slow loss of lean body mass. 
Later a liquid protein very low calorie diet 
(VLCD), with the protein a collagen hydro-
lysate was publicised by a book “The last 
Chance Diet” and over 100,000 people in USA 
used this product in 1976. 17 people died 
from ventricular fibrillation and it was 
thought that the poor amino acid pattern of 
the protein (hence biological value), or 
potassium depletion were probably 
responsible [71, 72]. 
A British COMA subcommittee concluded, 
inter alia, that VLCDs are not suitable for 
people with heart disease, pregnancy or 
lactation and should not be used beyond 4 
weeks [73]. 
Meanwhile Baird and Alan Howard had 
tested different low calorie supplements with 
a starvation diet and found that addition of 
30-45g carbohydrate would further increase 
the protection of nitrogen loss achieved by 
30g per day good biological value protein 
[74]. With the addition of all required vitamin 
and inorganic micronutrients this was 
patented in the USA as the Cambridge diet 
(330 Kcal/day) and is still widely used today. 
The second approach was to bring in the 
help of PSYCHOLOGISTS. RB Stuart intro-
duced behaviour therapy for obesity in a 
paper in a specialised journal far from obesity 
doctors in 1967 [75]. The principles start: 1. 
Eat in one place, 2. Buy non fattening foods, 3. 
Look for and change times of your own 
weakness, 4. Train others to help you curb 
your eating, 5. Make small portions appear 
large and make second helpings hard to get, 6. 
Take steps to avoid loneliness, depression, 
hunger, 7. Always eat four regular, planned 
meals a day… 11. Build in some pay-off for 
following every step of this program [76]. 
In an early controlled trial Pennick com-
pared weight reduction results between 
experienced obesity specialists and an inex-
perienced doctor using a behaviour modify-
cation (BM) script. BM was much more 
effective [77]. In another controlled compari-
son of an appetite suppressant drug and BM, 
weight fell faster on the medication, but by 12 
months weight was lower in the BM group – 
and this treatment had cost less [78]. 
Stuart moved to be psychological director 
of Weight Watchers (which had started as a 
small organization in 1962) [79]. 
Behaviour modification is now incorpo-
rated in all orthodox management pro-
grammes for obesity and a recent article in 
Scientific American [80] concluded that 
programmes based on behavioural principles 
are more likely to help people take and keep 
the weight off than other approaches. 
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There have been three other approaches: 
• Pop diets [81] come and go. At a 2010 
exhibition at the Welcome Institute in 
London there was a high bookcase with 
about 500 different books, each presenting 
their own reducing diet! 
• Then there are commercial programmes, 
some with lecturers, some with products, 
some following a book. Published con-
trolled trials are rare. The BBC, with 
nutrition and dietetic academics ran a 
comparison of four British programmes 
with a control group. The best of these, 
Weight Watchers clients lost (mean) 6.6 kg 
in 6 months [82]. 
• Surgery is obviously only indicated for 
people with severe obesity, but they have 
greater surgical risk than thin people. The 
first procedure used, from 1956 was jeju-
noileal bypass [83]. About 36 cm of the 
proximal jejunum was anastomosed to the 
last 10 cm of the terminal ileum (end to 
side). The distal part of the divided 
jejunum was closed, leaving most of the 
small intestine as a blind loop. The inten-
ded malabsorption and sustained loss of 
weight were achieved but there were 
serious side effects beyond expected diar-
rhoea: hypoalbuminaemia, many nutri-
tional deficiencies, arthritis, even liver 
failure. Weight loss was due to reduced 
food intake as well as malabsorption [84]. 
For some patients the by-pass had to be 
reversed. Hocking et al reviewed 100 of 
their cases 5 years after surgery: only half 
had unquestionably benefited. They and 
other surgeons stopped performing this 
operation [85]. 
 
And there are also people who lose weight 
without any professional or commercial 
advisers. The US National Weight Control 
Registry was established in 1994 for those 
who have lost 30 kg and maintained at least 
half of it for 5 years. Of the 784 in the register 
(in 1997), 45% said they had done it on their 




A UNIVERSAL STANDARD WEIGHT FOR 
HEIGHT 
After controversies over revision of desirable 
weights and (undefined) frame sizes, in the 
USA and relative weight and Broca’s index, 
used in Europe, these and other measures 
were quietly replaced across the world by 
weight (kg)/height(in metres)2, the redis-
covered “Body Mass Index” (BMI), first pro-
posed by the Belgian astronomer, Quetelet 
around 1871. Keys (1972) had concluded 
that, in the absence of skinfold measure-
ments, BMI provided the most satisfactory 
index of obesity, based on height and weight 
[88]. The DHSS/MRC report on obesity 
research (1976) calculated that 120% of US 
“desirable” weight would be a W/H2 of 27.5 
to 29.9 for men of medium to large frame size, 
and 27.0, to 29.5 for women [89].  Garrow 
sensibly rounded the values in his practical 
1981 book [90], so a W/H2 above 30 is taken 
to mean obesity in men and women. The 
Australian NH&MRC adopted the BMI in 1985 





This is the hypothesis that some people can 
waste calories as heat and not put on body fat 
if they eat more than they require. Dr Reg 
Passmore was a possible example. A tail coal 
made for him at 21 still fitted at age 65 [92]. 
The term had been introduced by Neumann 
in 1902 [93]. In 1967 Miller and Mumford 
[94] reported experiments in which they and 
two sets of students ate excess calories for 
weeks and did not put on the expected weight 
gain. Reviewing this and other work, Garrow 
found it impossible to conclude either that 
thermogenesis, or luxus consumption, does 
occur in man, or that it does not [16]. 
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Rats only eat to requirement, but when 
provided with “cafeteria food” instead of 
chow they overfed in Rothwell and Stock’s 
experiments [95] though they did not gain the 
body fat expected. They showed increased 
activity of brown adipose tissue (BAT). 
However it seems unlikely adult humans have 
enough BAT for this to make more than a 
small percentage change to overall energy 
balance [96]. Later detailed overfeeding 
human studies in Cambridge did not show 
diet-induced thermogenesis [97]. 
 
 
CALORIES (INCOMPLETELY) REPLACED BY 
JOULES 
In 1972 the Royal Society in Britain and 
several other scientific academies agreed that 
the Calorie should be replaced by the Joule for 
measuring energy metabolism and energy  
 
value of foods. Most countries followed suit. 
Scientists may have to use official SI units in 
the laboratory but it is unfortunate that the 
kilojoule and megajoule were imposed on 
ordinary people because, they are 
inconvenient sizes for foods, and there is 
bilingualism. Much nutritional information 
comes from the USA, where the public has 
held on to the Calorie. Thomas Moore’s 





FOOD INTAKES OF OBESE PEOPLE 
There have been repeated reports that obese 
people do not necessarily eat more than 
average (eg. ref [99]). 
WPT James et al measured the resting 
metabolic rate (RMR) of 69 obese patients 
(mean BMI 37) with a ventilated hood 
system. Almost all of them had a rate, in 
MJ/24hrs. higher than that of age-matched 
normal weight subjects [100], but when 
expressed in the traditional way, per surface 
area most of the obese patients RMR/m2 were 
in the normal range. The amount of RMR 
above expected normal was proportional to 
their excess body weight. When some of the 
patients successfully lost weight their 
absolute RMR fell to normal. Lean body mass, 
from 40K measured in a whole body counter 
was increased in the obese patients, in 
comparison to normal weight volunteers,  
 
and this contributes to RMR. 
The doubly labelled water (DLW) method 
[92] is one of the greatest recent discoveries 
in nutrition. With DLW a group in Cambridge 
reported in 1986 that [9] obese young 
women had energy expenditure of 10.2 
MJ/day, while it was 8 MJ/day in [13] lean 
women [102]. Self recorded energy intakes 
were close to DLW energy expenditure in the 
lean subjects, but in the obese, they were only 
66% of the DLW value. Since energy intake 
must balance energy expenditure in people at 
stable weight, it was at last clear that 
statements of food and energy intake – which 
The doubly labelled water method is the only objective way to estimate energy 
expenditure over several days. The subject drinks water containing heavy hydrogen, 
2H and heavy oxygen, 18O. The hydrogen mixes with body water; the oxygen goes into 
produced CO2 as well as body water. The difference in the decline of 18O minus 2H in 
the urine samples indicates CO2 production, and hence energy expenditure. 
Neither isotope is radioactive. They have to be measured with a sensitive mass 
spectrometer. The 18O oxygen isotope is very expensive. 
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are essentially subjective – are likely to be 




It is a popular observation that overweight 
tends to run in families. From 1986 ingenious 
large human studies were published using 
Mendelian methods. Stunkard et al investi-
gated 540 adults who had been adopted in 
Denmark (where there is a national adoption 
register). There was a strong relation bet-
ween their weight class and the BMI of their 
BIOLOGICAL parents, but not with their 
adoptive parents who they grew up with 
[104]. Bouchard et al overfed 12 pairs of 
young adult male monozygotic twins for 84 
days under controlled conditions. There was 
3 times less variance in weight and fat gain 
within pairs than among pairs [105]. BMIs of 
middle-aged identical twins that had been 
reared apart had high interpair correlation, 
almost as high as those reared together [106]. 
Obese identical twin women lost weight on a 
very low calorie diet for 1 month in a hospital 
metabolic unit in Prague. Losses (ranging -5.9 
to -12.4 kg) were highly correlated within the 
twin pairs [107]. There seem to be many 
genes responsible, working in different ways. 
They wait to be precisely implicated, by the 
new techniques of nutrigenomics [108]. The 




UNEXPECTED SURGE IN OBESITY FROM 
1980 
Unpredicted, unexplained and not noticed 
until the early 1990s, the prevalence of obese 
(BMI >30kg/m2) adults increased alarmingly 
in major countries in the 1980s & 1990s. 
Long series of numbers from national 
measured samples were most adequate for 
the USA (Fig 1). In Australia an increase in 
obese adults in the late 1980s was captured 
by three surveys in major cities by the 
National Heart Foundation. For men preva-
lence of obesity was 7.2% in 1980, 6.4% in 
1983 and 9.3% in 1989. In women it was 
7.0% in 1980, 8.7% in 1983 and 11.1% in 
1989 [102, 103, 104]. The rate continued to 
increase to 17% in men and 20% in women 
by 2000 [115]. 
 
Figure 1: USA per cent Obese (BMI>30kg/m2) 



















Based on [110] and [111], numbers rounded. 
 
In the UK obesity increased from 1980; 
comparable national sample measurements 
before this are not available. Between 1980 
and 2000 the percentage of obese men 
increased from 6% to 22% and obese women 
from 8% to 23% [116]. 
Prevalence´s of obese children increased 
in the same period in some countries [116], 
[117] though there are fewer long-term 
national measurements, and the lack of a 
common standard for defining obese children 
makes this difficult [118]. 
Around the whole world data have 
accumulated that overweight and obesity 
have increased in almost all countries [118, 
119, 120]. This must be due to environmental 
changes; genetic mutations could not occur so 
quickly and in so many places. 
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The immediate impact of this epidemic of 
overweight and obesity on disease risk is not 
as severe as it would have been in the 1950s. 
Hypertension and hypercholesterolaemia are 
now separately controllable by medications, 
and in the USA and Canada the relative risk of 
mortality is no longer increased in 
overweight people (BMI 25 to 30) [121, 122]. 
However death rates from diabetes increased 
by 33% from 1980 to 1996, while stroke and 
cardiovascular disease mortality were 
decreasing by about the same amount in the 
USA [123]. The prevalence of diabetes has 
increased worldwide [124]. 
Final proof of the causative association of 
type 2 diabetes with overweight came from 
two large important human trials of lifestyle 
intervention in Finland [125] and the USA 
[126, 127] in obese people with impaired 
glucose tolerance. The intervention groups in 
these randomised controlled trials received 
regular personal advice from a nutritionist 
and an exercise trainer. They lost around 5% 
of body weight, ate less saturated fat and 
more dietary fibre and increased regular 
physical exercise. Lifestyle intervention in 
both trials resulted in a 57% reduction in the 
incidence of diabetes in these high risk 
people. In the American Diabetes Prevention 
Program lifestyle intervention was 
significantly more effective in preventing 
diabetes than metformin [127]. 
 
 
SCARCITY OF EFFECTIVE, SAFE DRUGS FOR 
OBESITY 
In 1998 George Bray, doyen of American 
obesity physicians, wrote a sad editorial 
[128]: “The history of drug treatment of 
obesity is indeed strewn with catastrophes”. 
The pharmacologic treatment of obesity was 
(probably still is) analogous to what was 
available for hypertension in 1958, before 
chlorothiazide. 
Thyroid extract was first used in 1894 but 
it became clear that it could be harmful unless 
there was evidence of hypothyroidism. 
Amphetamine (benzedrine, dexedrine) was 
the first appetite suppressant, an indirect-
acting sympathomimetic amine. It was the 
drug for obesity in the first (1953) edition of 
Davidson’s textbook of medicine [30], but by 
the mid 1970s concerns were increasing 
because of the risk of dependence and 
psychotic states, as well as insomnia and 
increased blood pressure. “Speed” is illegal 
today. 
It was replaced by modified phenylethyla-
mines, diethylpropion (Tenuate), phenter-
mine (Duromine) and phenmetrazine (Prelu-
din) in the 1960s, which had less cerebral sti-
mulating activity. They were in turn replaced 
by fenfluramine. This still has the phenylethy-
lamine skeleton but is modified by CF3 on its 
benzene ring. It has serotoniergic, not cate-
cholinergic actions and is not a cerebral 
stimulant. In 1997 fenfluramine (Ponderax), 
dexfenfluramine (Adifax) and phentermine 
were the only appetite suppressants in the 
British National Formulary. They were 
recalled that year because of reports of 
primary pulmonary hypertension [129] and 
mitral valve disease [130] associated with 
their use. There is now no safe appetite 
suppressing drug on the market. Then 
sibutramine came and went [131]. 
With a different mode of action, Orlistat 
(Xenical) inhibits pancreatic lipase, so 
reduces fat absorption and acts outside the 
main body. Adverse effects include oily stools, 
faecal urgency, flatus. 
 
 
LEPTIN AND GHRELIN STIMULATE BASIC 
RESEARCH 
At about the time fenfluramine was with-
drawn, obesity research was excited by 
announcement in quick succession of two 
new hormones that expand the already 
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complex knowledge of control of energy 
balance. 
Discovery of leptin at the end of 1994 
[132] stimulated more than 600 papers in 
four years, moving modern molecular biology 
into the field of obesity research [133]. 
Leptin is the protein expressed by the OB 
gene, the gene missing in OB obese mice. It is 
synthesized in white adipose tissue and 
supresses food intake. This is the lipostatic 
hormone predicted in 1953 [61]. Injected 
leptin reduces weight and body fat in OB 
obese mice and had a modest weight reducing 
effect in humans. It was expected that most 
obese people would have reduced plasma 
leptin levels, but this proved incorrect; they 
appear to have resistance to leptin in the 
hypothalamus, where it normally inhibits 
NPY and AgRP synthesis. 
Humans with very low leptin and obesity 
are very rare, having a recessive mutation in 
the leptin gene [134]. Their obesity is severe, 
starts in childhood and responds to conti-
nuing leptin injections. 
In 1999 a new peptide that affects appetite 
was discovered in the stomach, Growth 
Hormone Releasing Endogenous Ligand – 
Ghrelin [135]. Very soon much more was 
found out about it. Ghrelin is produced by 
endocrine type cells in the submucosal layer 
of the stomach. It has 28 amino acids and the 
active form is acylated near one end with n-
octanoic acid. It is secreted when animals and 
people are hungry and plasma levels go down 
after meals. In the hypothalamus it stimulates 
the synthesis of NPY and AgRP. Plasma 
ghrelin is very high in Prader-Willi syndrome 
[136]. 
It appears that ghrelin acts mainly as 
appetite stimulant in short term regulation of 
appetite, while leptin has a longer term 
controlling role. Three other gut hormones 
are secreted lower down the gastrointestinal 
tract and all act to slow or stop eating. 
Cholecystokinin (CCK) was discovered and 
named by Ivy and Oldberg in 1928 [137]. Its 
satiating activity has been known since 1978 
[138]. It is secreted in response to a meal by 
the upper small intestine. Glucagon–like 
peptide 1 (GLP-1) secreted by the distal small 
intestine was first shown to reduce appetite 
in 1996. Peptide YY3-36 (PYY) is secreted by 
the large intestine, triggered by fatty acids, 
fibre and bile acids. Its post-meal satiety 
effect has been studied since 2002. Plasma 
PYY levels may be lower in obese people. 
In the last decade, along with these gastro-
intestinal hormones, research on the 
biochemistry and functions in the hypotha-
lamic nuclei has intensified. 
Peripheral hormones acting on the hypo-
thalamus are insulin, adiponectin (from 
adipose tissue, discovered 1995), leptin, 
ghrelin, CCK, GLP-1, PYY and vagal efferents. 
Inside the hypothalamus [139], neuro-
peptide Y (NPY) and agouti –related peptide 
(AgRP) stimulate appetite. POMC (pro-
opiomelanocortin) and CART (cocaine and 
amphetamine-related transcript) are inhibi-
tory. The arcuate, ventromedial and lateral 
nuclei and others are differently involved and 
beyond them the nucleus of the solitary tract, 
and the reward center, the nucleus accum-
bens. 
Food intake is of course also influenced by 
the higher cortical centers. All the messenger 
proteins and neurotransmitters have multiple 
chemical forms and interact with one another 
and with the other endocrine systems. The 
comprehensive review by Katie Wynne et al. 
has 27 pages and 450 contemporary refer-
ences [139]. John Blundell has specially 
studied eating regulation, satiation and 
satiety in humans in the last 20 years (3
He reviews food intake behaviour from the 
peripheral side 
). 
[140] As Time magazine put it 
“understanding a single biological unit – the 
heart, the lungs – is hard enough. Under-
 
(3) Satiation is the complex of factors that terminate an eating 
episode. 
Satiety (or between meals satiety) is the processes that inhibit 
further eating in the postprandial period [140]. 
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standing a process as complex as appetite – 
one that involves taste, smell, sight, texture, 
brain chemistry, gut chemistry, metabolism 
and most confounding of all, psychology – is 
exponentially harder – but science is trying” 
[141]. 
It will be difficult to find a drug to block 
one of the orexigenic (appetite stimulating) 
agents because NPY null mice have normal 
body weight and fat [142] and ghrelin 
knockout mice have similar body weight gain 
and food intake to wild-type mice [143]. 
 
 
WHY HAS THE OBESITY EPIDEMIC 
HAPPENED? 
There are three possible immediate causes of 
the rising prevalence of obesity since 1980: 
a) Energy intakes exceeding expenditure, 
b) Less energy expenditure, 
c) Less smoking 
 
The difficulty allocating blame is that we have 
to rely on national estimates and in each 
country there should have been a major 
increase of the population’s energy intake or 
decrease of energy expenditure related in 
time to the steepest increase in overweight 
and obesity. 
a) Reports on national food consumption 
are based on crude figures and assumptions. 
There is even less accurate recording of the 
many types of food waste, so these estimates 
do not record what people actually eat. An 
example of this is the paper by Swinburn et al. 
[144] “Increased energy supply is more than 
sufficient to explain the US epidemic of 
obesity”. An alternative method uses indi-
vidual intakes. Farouhi et al. report on 89,432 
men and women in 6 combined west Euro-
pean EPIC cohort studies [145]. No significant 
association was found between fat intake 
(amount or type) and subsequent weight 
gain. But here the weakness is that fat people 
under-report; food frequencies are better for 
estimating quality rather than quantity of 
diets and fat intake is the macronutrient most 
likely to be under-reported. 
There have been many claims that some 
parts of the total food supply have 
contributed to overeating: fast food outlets 
(McDonalds and others), sugar-rich carbo-
nated beverages (Coca cola and others), more 
advertising of foods dense in energy, cheaper 
energy-dense foods (high in fat, sugar and 
salt), increased portion size, increased plate 
size and loss of skills in domestic cookery. It 
is also very possible that anxieties in people 
with low socio-economic status lead to 
overeating. Probably all have contributed to 
some extent. 
b) That energy expenditures have declined 
is more certain. The largest contribution must 
be the enormous increase in motorcars, hence 
reduced walking or cycling and carrying. In 
all aspects of domestic and professional life 
there are now labour/energy saving ma-
chines. A few examples: lifts, automatic doors, 
washing machines, mobile phones, power 
tools, chain saws, mechanical harvesters, 
cranes, milking machines, bar code scanners, 
robot machines in factories, diggers, even golf 
buggies. 
Television viewing and computer use have 
replaced more active domestic and office 
activities. Hours per week of television 
viewing have been associated with weight 
gain [146]. 
An argument for reduced energy intake 
was well made by Andrew Prentice and Jebb 
[147]. Percentage of obese people in Britain 
increased steeply from 1950 to 1990 and cars 
(per household) went up in parallel, but 
energy intake appears to have declined 
slightly. Energy intake here was from the 
National Food Survey. This is a survey of 
household food intakes, unique to Britain, 
continuous from 1940. The weakest part of 
this survey is Eating Out which has been 
added from 1994 [148]. 
To increase energy expenditure is harder 
work than eating less as a way of losing 
Nutrition and Medicine 2013, 1(1): 2 
Page 16 of 25 
 
 
weight. Derek Miller used to upset people by 
his (reasonable) estimation that to lose 1lb of 
body fat (0.45kg) the activity equivalent is to 
walk from London to Brighton (52 miles; 
83km) [149]. In weight reduction the time 
scale is much shorter and contrasts with the 
gradual process of putting on weight over a 
number of years. The American obesity 
epidemic, in absolute terms is caused by most 
people gaining small amounts of weight 
slowly: around 4kg over a generation [150]. If 
all the weight is fat this amounts to + 36,000 
Kcal over 3,650 days or + 10 Kcal a day. The 
energy expenditure equivalent is 2.5 minutes 
walk per day. If the weight was doubled or 
the time halved, 5 minutes walk/day. 
c) Tobacco smoking. The obesity epidemic 
coincided in time with the decline of smoking 
in Western countries. Smokers weigh 2 to 6 
kg less than non smokers and if they manage 
to stop smoking they put on weight [151]. 
Nicotine, the active ingredient in tobacco 
smoke, suppresses appetite and also appears 
to increase metabolism. The percentages who 
have quit smoking have not been large 




WHAT IS THE BEST WEIGHT-REDUCING 
DIET? 
The principle of a conventional reduced 
energy diet has been to target visible fats and 
sugar and retain the parts of the ordinary diet 
that supply most essential nutrients. David-
son’s textbook (1953) recommended for 
obesity a diet of 1,000 calories with 100 g 
carbohydrate, 60 g protein and 40 g fat 
(C/D/F 40,24,36% energy) [30]. This 
continued through 16 successive editions. 
Though the fat is about half that in a usual 
diet it is not proportionately low, which 
makes possible a range of allowed foods. The 
WHO obesity report (2000) [109] recom-
mended a reducing diet with 55-60% carbo-
hydrate, 15% protein and 20-30% fat, which 
is absolutely and proportionately low in fat. 
These two diet plans illustrate the range of 
conventional weight-reducing prescriptions. 
There have been numerous named special 
diets for obesity. They have been ephemeral 
and not had major impact on the scientific 
and medical establishment. But Dr. Atkins 
Diet Revolution first published as a 
paperback in 1972 [152] became a best seller. 
The principle was a very low carbohydrate, 
consequently high fat and protein diet. Total 
carbohydrate should be only 20 to 40 g per 
day. This causes ketosis and loss of appetite. 
The Atkins diet was condemned by the 
American Medical association [153] and the 
Australian NH&MRC and a textbook of 
nutrition [92]. It would raise (LDL-) choles-
terol and ketosis is not healthy. But many 
ordinary people in the USA and beyond found 
this diet plan helped them lose weight. The 
food industry reacted, Atkins wrote another 
book (1992) [154] and nutrition researchers 
were obliged to organise randomised con-
trolled trials. 
Five well conducted trials reported from 
2003-9, with subjects ranging from 
overweight to severely obese. Atkins diets 
were compared with low fat and (in two 
trials) with other popular diets. Those taking 
Atkins diets lost more weight at first, but by 6 
months [82] or by 1 year [155, 156] weight 
loss was not significantly different from the 
low fat diets. In a fourth trial there was less 
weight loss at 1 year with Atkins than with 
Weight Watchers, Zone or Ornish diets [157]. 
In these trials LDL-cholesterol fell less on 
Atkins than on conventional weight loss 
regimes but HDL-c was higher and triglyce-
rides were lower on the very low carbo-
hydrate diets. 
A large trial (2009) in Boston and Baton 
Rouge (Louisiana) compared four weight loss 
diets – high or moderate protein, usual or low 
fat [158]. 811 people started and 80% 
completed 2 years. They were given diet 
plans, offered regular group sessions and 
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periodic individual sessions. Subjects looked 
after their own food. They were asked to keep 
daily diet diaries and had 3 telephone inter-
views at 6 and 24 months. 
They lost an average of 6 kg at 6 months 
and then tended to regain weight. The 
completers lost (mean) 4kg over 2 years. 
There were no significant differences in 
weight loss between the four diet groups but 
many did not achieve or maintain their 
prescribed protein or fat intakes. Attendance 
at sessions had a strong association with 
weight loss: Participants who came to two-
thirds of the sessions lost 9 kg of weight. 
At about the same time another large trial 
[159] was carried out in 8 European 
countries, the Diogenes study (2010). Design, 
management and results were different from 
the American trial. Over 26 weeks, high 
protein and low glucaemic index diets 
reduced weight regain in 773 adult subjects 
who had first lost 8% of initial weight (with a 
3.3 MJ (800 Kcal) diet in 8 weeks). 
Here the high protein group had 
significantly higher urinary nitrogens. 
Diogenes showed that the satiating effects of 
increased protein (as in Atkins diets) could be 
effectively combined with moderate carbo-
hydrate intake, avoiding disadvantages of 
high fat diets. 
In these large weight loss trials that 
compared the efficiency of different diets 
most participants did not actually eat their 
prescribed diets and over time more subjects 
dropped out. Analysis by standard “intention 
to treat” can have little meaning, but those 
who persisted with close to their prescribed 
diet lost most weight. Astrup and Pedersen 
admit they would not personally like to be 
enrolled in a randomised controlled trial with 
the prospect of eating the same extreme diet 
every day for 12 months without any 
deviation [160]. 
Katan underlined the conclusion of Sacks 
et al [158] that “behavioural factors rather 
than macronutrient composition are the main 
influences on weight loss”. Even these highly 
motivated, intelligent participants who were 
coached by expert professionals could not 
achieve the weight loss needed to reverse the 
obesity epidemic… We do not need another 
diet trial; we need a change of paradigm”. 
As an example he points to the EPODE 
programme that started in two small French 
towns and is spreading. EPODE is Ensemble, 
prévenons l’obesité des enfants (together let’s 
prevent obesity in children). Everyone in a 
town, from the mayor to shop owners, school 
teachers, doctors, pharmacists, caterers, 
restaurant owners, sports associations, the 
media, scientists and various branches of 
town government joined in an effort to 
encourage children to eat better and move 
around more [162]. 
The small weight losses with expert 
professional help have confirmed that for 
obesity prevention is much better than cure, 
and health professionals cannot do the 
prevention on their own [163]. We need the 
active cooperation of the whole community. 
In the Foresight report, commissioned by the 
UK Government [164] are Obesity System 
Maps. The full generic map has 104 variables 
in 7 groups: social psychology, food produc-
tion, food consumption, individual psycho-
logy, physical activity environment, individual 
physical activity and physiology – all inter-
acting ultimately with ENERGY BALANCE in 
the centre. The 104 individual variables 
include ambient temperature, convenience, 
cost of food ingredients, cost of physical 
exercise, force of (food) habits, food 
abundance, food literacy, lack of time, level of 
occupational activity, level of recreational 
activity, market price of food offering, NEAT 
(non-exercise activity), palatability of food 
offerings, parental control, perceived 
inconsistency of scientific messages, predis-
position to activity, reliance on labour-saving 
devices, safety of unmotorised transport, 
societal pressure to consume, stress, walka-
bility of the living environment, &c. 
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BARIATRIC SURGERY RETURNS FOR GROSS 
OBESITY 
After decades in obscurity, bariatric surgery 
has emerged as an effective treatment for 
type 2 diabetes [169]. For someone with 
gross obesity and diabetes medical treatment 
is difficult and sufficient weight loss very slow 
and unlikely. Modern bariatric surgery is 
achieving weight loss of 20% or more with 
remission of the diabetes in many patients. 
The International Diabetes Federation 
considers it is a serious option if BMI is 35 
kg/m2 or more [166]. 
The Roux-en-Y gastric bypass was intro-
duced by Mason in the 1960s [167]. A small 
fundal portion of the stomach is separated 
from the body of the stomach (which is 
closed) and anastomosed to a loop of 
jejunum. Alternatively the stomach can be 
reduced in volume by banding. These 
procedures can often be done nowadays 
using keyhole techniques. Operative mortality 
is only about 0.1 to 0.3 % [166] and over 6 
years mortality in a large American series 
was lower than in controls with similar BMI 
and age [168]. With gastric bypass, ghrelin 
and GIP levels are reduced [169], the opposite 
of their increases with diet-induced weight 
loss. The UK National Bariatric Surgery 
Registry reports that costs of surgery are 
recouped in 3 years, by savings of treatment 
of diabetes and cardiovascular disease [170]. 
Of course the most cost effective policy is to 
make sure that people do not get to the stage 




The basic research behind obesity is Physics – 
energy balance, energy content of foods, the 
laws of thermodynamics, conversion of 
chemical energy to heat and movement. Yet 
people’s intake and expenditure of energy 
happens in the fields of Psychology and 
Sociology. Overweight and underweight are 
routinely assessed by weighing a person, with 
adjustment for height, usually kg/metres2 
(BMI) since 1985. But this doesn’t tell how 
much of the weight is fat, how much are 
muscles. 
It is remarkable that most adult people 
maintain an almost constant weight over long 
periods of time without calculating their 
energy balance. Research is showing 
powerful and complex mechanisms for 
adjustment of appetite and energy 
expenditure, involving especially the gut and 
the hypothalamus. Because of this, loss of 
weight is less than the expected 1.0 kg for 
eating a deficit of 7,000 calories [121]. 
Some genetic control is obvious from 
Mendelian human studies, though the main 
individual genes at play await discovery. 
When people take in less energy than they 
need, their metabolic rate goes down faster 
than their body weight – which helped our 
species survive food shortages. 
There are two concepts of obesity. One is 
social (and varies with the society); the other 
is medical, the BMI at which risk of disease 
starts to increase. Hippocrates observed that 
very fat people are apt to die younger than 
slender people. In the first half of the 20th 
century life insurance actuaries found that 
above a weight-for-height corresponding to a 
BMI of 25kg/m2 mortality started to increase. 
The WHO classified BMIs between 25 and 30 
as “overweight” with “obesity” above 30 
kg/m2. However in the last years of the 20th 
century (in USA and Canada) BMIs 25 to 30 
were not associated with increased mortality, 
though there was more diabetic morbidity. 
There was an unexpected surge in 
overweight and obesity starting around 1980 
in developed countries and beyond. Faced 
with this, doctors and dietitians find it very 
difficult to treat obesity. Physicians are 
accustomed to treat most complaints with 
medication, but obesity stands out as having 
no effective safe pharmacotherapy. Dietitians 
are accustomed to treat patients with diet 
plans – how much to eat of which foods at 
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each meal, but it has become clear that most 
obese people cannot manage to follow their 
diet prescription. “Doctor has put me on a 
diet”, but the diet is on paper, not in their 
stomach. With obesity it’s not the health 
professional that does the treatment, it’s the 
fat person themselves – and some people can 
achieve substantial weight reduction without 
professional help. They have great difficulty, 
unfortunately in visualising the calorie value 
of foods and drinks as easily as they can see 
their dollar value. We are all very confused by 
Calories, kilocalories, kilojoules and mega-
joules and whether these are per 100 g (even 
kg) or per usual serving. 
When type 2 diabetes is part of the diagno-
sis, weight reduction is more than cosmetic 
and preventive, it is a major part of the 
medical management because weight loss 
alleviates and can cure diabetes. Diabetolo-
gists in the second half of the 20th century 
focused on different types of insulin and 
drugs and neglected dieting. They had for-
gotten that Joslin showed back in 1921 that 
“diabetes is largely a penalty of obesity”. 
Many strategies have been tried to help 
with weight reduction: very low calorie diets 
(VLCDs); many celebrity named diets; 
commercial diet instructors; behaviour modi-
fication; low fat, or the opposite – low carbo-
hydrate “Atkins” diets. The Cambridge diet 
looks the best of VLCDs; Weight Watchers 
have performed best in trials of commercial 
diets. Behaviour modification was shown, 
round 1970, to help more than usual advice 
and some of its methods are now commonly 
used. In Atkins (type) diets the extra protein 
provides satiation and some thermogenic 
effect. Several large trials have found rather 
more weight loss with low carbohydrate than 
with other low calorie diets in first months, 
but not later. It is very hard for anyone to eat 
the same weight-reducing diet month after 
month, even with trained support. So what 
was eaten in the trials published in high 
impact journals was not actually the planned 
food prescription. The only doctors who can 
directly TREAT obesity are bariatric surge-
ons. With advances in surgery, gastric 
banding and gastric bypass are now serious 
options for very obese people with diabetes. 
The food and drink industries have been 
the background of the obesity epidemic and 
so has agriculture’s efficiency in making foods 
much cheaper. Fogel( 4
[172
) has shown these 
achievements over the last one & a half centu-
ries made major contributions to longer life 
expectancy and economic growth ]. The 
recent overshoot of society’s energy balance 
now requires polices and work by sections of 
society beyond the health profession. General 
practitioners should, however, measure and 
record weights regularly and advises over-
weight patients how to minimise further 
weight gain. 
Obesity, like tetanus and poliomyelitis, is 
much easier to prevent than cure. Lack of 
exercise at work, in transportation and in 
recreation is part of the explanation for the 
obesity epidemic. Health professionals cannot 
correct it on their own. Town planners, archi-
tects, developers and schools should all work 
to make it easier for people to get recrea-
tional exercise and to move more by walking 
and cycling. Caterers at all levels should be 
seriously aware of the calorie contents of the 
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